Bank of America’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-13,424
Closed -$60K 8332
2023
Q4
$60K Buy
13,424
+1,577
+13% +$5.42K ﹤0.01% 6548
2023
Q3
$17.7K Buy
11,847
+837
+8% +$1.59K ﹤0.01% 6728
2023
Q2
$25.1K Sell
11,010
-1,773
-14% -$4.08K ﹤0.01% 6655
2023
Q1
$25.1K Buy
12,783
+251
+2% +$520 ﹤0.01% 6696
2022
Q4
$20.6K Buy
12,532
+4,355
+53% +$6.79K ﹤0.01% 6729
2022
Q3
$16K Buy
8,177
+7,174
+715% +$17.2K ﹤0.01% 7115
2022
Q2
$2K Buy
1,003
+929
+1,255% +$3.15K ﹤0.01% 7815
2022
Q1
$0 Sell
74
-84,282
-100% -$348K ﹤0.01% 8931
2021
Q4
$519K Buy
+84,356
New +$963K ﹤0.01% 5826

Other funds holding LIAN

Bank of America's LIAN Position: Q1 2024 in Review

Bank of America sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 13,424 shares — an estimated $60K sold.

Bank of America first reported a position in LIAN in Q4 2021 and held it in 9 quarters. The position peaked at $519K in Q4 2021. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

  • Bank of America reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Bank of America sold 13,424 LianBio American Depositary Shares shares in Q1 2024, an estimated $60K.
  • Bank of America first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 9 quarters.
  • Bank of America's LianBio American Depositary Shares position peaked at $519K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Bank of America's 13F filing for Q1 2024, filed 15 May 2024.